Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Jay Bradner joins Amgen as R&D head

by Laura Howes
January 5, 2024 | A version of this story appeared in Volume 102, Issue 1

 

Amgen has appointed Jay Bradner its new chief scientific officer. The former Novartis research leader succeeds David Reese, who has become Amgen’s chief technology officer. “The steps we are announcing today reflect our conviction that the rapid convergence of ‘biotech’ and ‘tech’ will unlock the next frontier of innovation in biotechnology,” Amgen CEO Robert Bradway says in a press release announcing the moves.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.